<DOC>
	<DOCNO>NCT00046111</DOCNO>
	<brief_summary>The purpose study compare two capsule topotecan make slightly different method . This do give drug make two different method patient orally test blood level .</brief_summary>
	<brief_title>A Bioequivalence Study Two Oral Formulations Topotecan Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Written inform consent Patients confirm advanced solid tumor . No prior chemotherapy within 5 year diagnosis SCLC ( small cell lung cancer ) . At least 4 week since last chemotherapy , radiotherapy , biologic therapy surgery . Laboratory criterion : Patients must adequate bone marrow reserve adequate kidney liver function . Exclusion criterion : Women pregnant lactating . Patients child bear potential refusing practice adequate contraception . Patients uncontrolled vomit . Active infection . Patients clinical evidence gastrointestinal ( GI ) condition would alter GI absorption GI motility . Patients require treatment cyclosporin A . Severe medical problem cancer , would limit ability patient follow study guideline expose patient extreme risk . Ongoing plan chemotherapy , immunotherapy , radiotherapy , investigational therapy cancer treatment . Use investigational drug within 30 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>oral</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Hycamtin</keyword>
	<keyword>Topotecan</keyword>
</DOC>